Pneumonitis

18 registered clinical trials studyying Pneumonitis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis NCT06860542	AHS Cancer Control Alberta	Phase 2
Recruiting	Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiat NCT06688422	The Cooper Health System	N/A
Not Yet Recruiting	A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii P NCT06670872	Peking University Third Hospital	—
Recruiting	Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor P NCT05455034	Xinqiao Hospital of Chongqing	Phase 1 / Phase 2
Unknown	Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP NCT05280873	Zhou Chengzhi	Phase 1
Completed	GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) NCT04590547	GeneOne Life Science, Inc.	Phase 2
Completed	Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) NCT04721444	Royal Marsden NHS Foundation Trust	—
Terminated	Tocilizumab for Patients With Cancer and COVID-19 Disease NCT04370834	National Cancer Institute (NCI)	Phase 2
Unknown	Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia NCT04326725	Istinye University	—
Completed	Accurate Classification System for Patients With COVID-19 Pneumonitis NCT04302688	Renmin Hospital of Wuhan University	—
Terminated	Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis NCT04040244	Wake Forest University Health Sciences	N/A
Terminated	Avoiding Neuromuscular Blockers to Reduce Complications NCT03962725	Beth Israel Deaconess Medical Center	Phase 4
Completed	Everolimus Related Pneumonitis in MBC NCT03730428	Fudan University	—
Completed	Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication NCT02246361	Floralis	Phase 4
Completed	Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease NCT03012958	National Jewish Health	—
Completed	Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies NCT02788643	CHU de Reims	—
Completed	Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients NCT00997555	Hurley Medical Center	N/A
Completed	Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis i NCT00081315	MedImmune LLC	Phase 2